There is insufficient evidence about the incidence, prevalence and racial predilection of<unk><unk> . However, the classic<unk><unk>  is disappearing after the removal of phenacetin from the markets over 30 years ago. Most patients with<unk><unk>  have been reported to be middle age or older with a history of chronic pain. Studies suggest that<unk><unk>  is more conman in females than males.
Analgesic nephropathy epidemiology and demographics
Contrast induced nephropathy epidemiology and demographics
Diabetic nephropathy epidemiology and demographics
Renal amyloidosis epidemiology and demographics
Hypertensive nephropathy epidemiology and demographics
Interstitial nephritis epidemiology and demographics
Kidney stone epidemiology and demographics
Acute tubular necrosis epidemiology and demographics